表紙
市場調查報告書

白內障手術設備市場:醫療設備的開發平台評估

Cataract Surgery Devices - Medical Devices Pipeline Assessment, 2019

出版商 GlobalData 商品編碼 227697
出版日期 內容資訊 英文 126 Pages
訂單完成後即時交付
價格
白內障手術設備市場:醫療設備的開發平台評估 Cataract Surgery Devices - Medical Devices Pipeline Assessment, 2019
出版日期: 2019年12月16日內容資訊: 英文 126 Pages
簡介

本報告提供全球白內障手術設備的市場上的主要開發中產品 (醫療設備) 及其臨床實驗進展之相關調查,再彙整產品特性比較分析 (臨床實驗的各進展階段) ,主要企業簡介及代表性產品,近來的市場動靜 (資本交易·產業聯盟等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 白內障手術設備市場概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各市場區隔
  • 開發中產品:各地區
  • 開發中產品:法規各途徑
  • 開發中產品:估計認證各時期
  • 開發中產品:現在進行中的臨床實驗

第4章 白內障手術設備:臨床實驗中的開發中產品 (各企業)

  • 白內障手術設備的企業:各臨床實驗階段的開發中產品
  • 白內障手術設備:各臨床實驗階段的開發中產品

第5章 白內障手術設備市場:企業·產品概要

  • Abbott Medical Optics, Inc.
    • 開發中產品及進行中的臨床實驗概要
  • Adoptics AG
  • Advanced Refractive Technologies, Inc.
  • AkkoLens International BV
  • Alcon, Inc.
  • Altacor Limited
  • Anew Optics, Inc.
  • Bausch & Lomb Incorporated
  • Calhoun Vision, Inc.
  • Elenza, Inc.
  • Eye Care and Cure
  • EyeKon Medical, Inc.
  • Glaukos Corporation
  • Hoya Surgical Optics, Inc.
  • HumanOptics AG
  • Imperial Medical Technologies, Inc
  • InnFocus LLC
  • Innovia LLC
  • International Biomedical
  • LensGen, Inc.
  • London Eye Hospital Pharma
  • Massachusetts Institute of Technology
  • Meir Medical Center
  • Morcher Gmbh
  • Mynosys Cellular Devices, Inc.
  • NuLens Ltd.
  • Oculentis GmbH
  • OptMed, Inc.
  • OptoLight Vision Technology
  • Paradigm Medical Industries, Inc.
  • PowerVision, Inc.
  • Presbeasy
  • Rayner Intraocular Lenses Limited
  • Rhexis Biomedical
  • Sharklet Technologies, Inc.
  • STAAR Surgical Company
  • Tear Diagno LLC
  • TEKIA, Inc.
  • University of Florida
  • University of Rochester
  • University of Texas Medical Branch at Galveston
  • Visioneering Technologies, Inc.
  • Wake Forest Baptist Medical Center
  • Washington University in St. Louis
  • Xend
  • Z Lens LLC
  • Ziemer Ophthalmic Systems AG

第6章 白內障手術設備市場:目前的趨勢

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0854EPD

GlobalData's Medical Devices sector report, "Cataract Surgery Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Cataract Surgery Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cataract Surgery Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cataract Surgery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cataract Surgery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cataract Surgery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 5
  • 1.2 List of Figures 7

2 Introduction 8

  • 2.1 Cataract Surgery Devices Overview 8

3 Products under Development 9

  • 3.1 Cataract Surgery Devices - Pipeline Products by Stage of Development 9
  • 3.2 Cataract Surgery Devices - Pipeline Products by Segment 10
  • 3.3 Cataract Surgery Devices - Pipeline Products by Territory 11
  • 3.4 Cataract Surgery Devices - Pipeline Products by Regulatory Path 12
  • 3.5 Cataract Surgery Devices - Pipeline Products by Estimated Approval Date 13
  • 3.6 Cataract Surgery Devices - Ongoing Clinical Trials 14

4 Cataract Surgery Devices - Pipeline Products under Development by Companies 15

  • 4.1 Cataract Surgery Devices Companies - Pipeline Products by Stage of Development 15
  • 4.2 Cataract Surgery Devices - Pipeline Products by Stage of Development 16

5 Cataract Surgery Devices Companies and Product Overview 17

  • 5.1 Advanced Refractive Technologies Inc Company Overview 17
    • 5.1.1 Advanced Refractive Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.2 Altacor Ltd Company Overview 18
    • 5.2.1 Altacor Ltd Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.3 Bausch & Lomb Inc Company Overview 19
    • 5.3.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.4 Cirle, Inc Company Overview 26
    • 5.4.1 Cirle, Inc Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.5 Dutch Ophthalmic Research Center International BV Company Overview 27
    • 5.5.1 Dutch Ophthalmic Research Center International BV Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.6 Eye Care and Cure Company Overview 28
    • 5.6.1 Eye Care and Cure Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.7 Hebrew University of Jerusalem Company Overview 29
    • 5.7.1 Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.8 Iantech Inc Company Overview 30
    • 5.8.1 Iantech Inc Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.9 International BioMedical Devices Inc Company Overview 31
    • 5.9.1 International BioMedical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.10 Medicontur Medical Engineering Ltd Company Overview 32
    • 5.10.1 Medicontur Medical Engineering Ltd Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.11 Mynosys Cellular Devices, Inc. Company Overview 33
    • 5.11.1 Mynosys Cellular Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.12 OptoLight Vision Technology Company Overview 35
    • 5.12.1 OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.13 Paradigm Medical Industries, Inc. (Inactive) Company Overview 38
    • 5.13.1 Paradigm Medical Industries, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 38
  • 5.14 Shanghai Haohai Biological Technology Co Ltd Company Overview 39
    • 5.14.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.15 STAAR Surgical Company Company Overview 40
    • 5.15.1 STAAR Surgical Company Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.16 Tear Diagno LLC (Inactive) Company Overview 41
    • 5.16.1 Tear Diagno LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 41
  • 5.17 University of California Los Angeles Company Overview 42
    • 5.17.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.18 University of Florida Company Overview 43
    • 5.18.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 43
  • 5.19 University of Michigan Company Overview 44
    • 5.19.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.20 University of Texas Medical Branch at Galveston Company Overview 45
    • 5.20.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.21 VSY Biotechnology BV Company Overview 46
    • 5.21.1 VSY Biotechnology BV Pipeline Products & Ongoing Clinical Trials Overview 46
  • 5.22 Wake Forest Baptist Medical Center Company Overview 47
    • 5.22.1 Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview 47

6 Cataract Surgery Devices- Recent Developments 48

  • 6.1 Nov 20, 2019: Baring Private Equity Asia signs agreement to buy Lumenis 48
  • 6.2 Nov 19, 2019: Alcon reports third quarter and nine months 2019 results 48
  • 6.3 Nov 12, 2019: Ocular Therapeutix reports third quarter 2019 financial results and business update 51
  • 6.4 Nov 06, 2019: Glaukos Corporation announces third quarter 2019 financial results 53
  • 6.5 Nov 04, 2019: Bausch Health Companies announces third-quarter 2019 results and raises full-year revenue and adjusted EBITDA (non-GAAP) guidance ranges 54
  • 7.1 Methodology 123
  • 7.2 About GlobalData 126
  • 7.3 Contact Us 126
  • 7.4 Disclaimer 126

List of Tables

  • Table 1: Cataract Surgery Devices - Pipeline Products by Stage of Development
  • Table 2: Cataract Surgery Devices - Pipeline Products by Segment
  • Table 3: Cataract Surgery Devices - Pipeline Products by Territory
  • Table 4: Cataract Surgery Devices - Pipeline Products by Regulatory Path
  • Table 5: Cataract Surgery Devices - Pipeline Products by Estimated Approval Date
  • Table 6: Cataract Surgery Devices - Ongoing Clinical Trials
  • Table 7: Cataract Surgery Devices Companies - Pipeline Products by Stage of Development
  • Table 8: Cataract Surgery Devices - Pipeline Products by Stage of Development
  • Table 9: Advanced Refractive Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Accupulse Cataract Emulsifier - Product Status
  • Table 11: Accupulse Cataract Emulsifier - Product Description
  • Table 12: Altacor Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: SOLO - Product Status
  • Table 14: SOLO - Product Description
  • Table 15: Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: BLS - 001: Cataract - Product Status
  • Table 17: BLS - 001: Cataract - Product Description
  • Table 18: BLS - 002: Cataract - Product Status
  • Table 19: BLS - 002: Cataract - Product Description
  • Table 20: BLS - 003: Cataract - Product Status
  • Table 21: BLS - 003: Cataract - Product Description
  • Table 22: BLS - 004: Cataract - Product Status
  • Table 23: BLS - 004: Cataract - Product Description
  • Table 24: BLS - 006: Cataract - Product Status
  • Table 25: BLS - 006: Cataract - Product Description
  • Table 26: BLS - 007: Cataract - Product Status
  • Table 27: BLS - 007: Cataract - Product Description
  • Table 28: BLS - 008: Cataract - Product Status
  • Table 29: BLS - 008: Cataract - Product Description
  • Table 30: BLS - 010: Cataract - Product Status
  • Table 31: BLS - 010: Cataract - Product Description
  • Table 32: BLS - 011: Cataract - Product Status
  • Table 33: BLS - 011: Cataract - Product Description
  • Table 34: BLS - 015: Cataract - Product Status
  • Table 35: BLS - 015: Cataract - Product Description
  • Table 36: BLS - 016: Cataract - Product Status
  • Table 37: BLS - 016: Cataract - Product Description
  • Table 38: Ophthalmic Viscosurgical Device - Product Status
  • Table 39: Ophthalmic Viscosurgical Device - Product Description
  • Table 40: Cirle, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 41: SNS 200 - Product Status
  • Table 42: SNS 200 - Product Description
  • Table 43: Dutch Ophthalmic Research Center International BV Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: EVA Phaco-Vitrectomy System - Product Status
  • Table 45: EVA Phaco-Vitrectomy System - Product Description
  • Table 46: Eye Care and Cure Pipeline Products & Ongoing Clinical Trials Overview
  • Table 47: Ophthalmic Device - Cataract Surgery - Product Status
  • Table 48: Ophthalmic Device - Cataract Surgery - Product Description
  • Table 49: Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview
  • Table 50: Ophthalmic Viscoelastic Device - Product Status
  • Table 51: Ophthalmic Viscoelastic Device - Product Description
  • Table 52: Iantech Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 53: Reusable Cataract Surgery Device - Product Status
  • Table 54: Reusable Cataract Surgery Device - Product Description
  • Table 55: International BioMedical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 56: ApertureRx Precision Capsulotomy System - Product Status
  • Table 57: ApertureRx Precision Capsulotomy System - Product Description
  • Table 58: Medicontur Medical Engineering Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: Pre-Filled Injection System - Product Status
  • Table 60: Pre-Filled Injection System - Product Description
  • Table 61: Mynosys Cellular Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 62: ZEPTO - Product Status
  • Table 63: ZEPTO - Product Description
  • Table 64: Zepto-PEDS - Product Status
  • Table 65: Zepto-PEDS - Product Description
  • Table 66: OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview
  • Table 67: Lipshitz Macular Implant - Diabetic Maculopathy - Product Status
  • Table 68: Lipshitz Macular Implant - Diabetic Maculopathy - Product Description
  • Table 69: OptoLight Vision Technology - Ongoing Clinical Trials Overview

List of Figures

  • Figure 1: Cataract Surgery Devices - Pipeline Products by Stage of Development
  • Figure 2: Cataract Surgery Devices - Pipeline Products by Segment
  • Figure 3: Cataract Surgery Devices - Pipeline Products by Territory
  • Figure 4: Cataract Surgery Devices - Pipeline Products by Regulatory Path
  • Figure 5: Cataract Surgery Devices - Pipeline Products by Estimated Approval Date
  • Figure 6: Cataract Surgery Devices - Ongoing Clinical Trials